<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Basophil activation test for the in vitro diagnosis of tocilizumab hypersensitivity</dc:title><dc:creator>Koren,	Ana	(Avtor)
	</dc:creator><dc:creator>Dejanović,	Luka	(Avtor)
	</dc:creator><dc:creator>Korošec,	Peter	(Avtor)
	</dc:creator><dc:creator>Kopač,	Peter	(Avtor)
	</dc:creator><dc:description>Basophil activation test (BAT) is a useful approach for diagnosing hypersensitivity reactions to tocilizumab. BAT offers insight into IgE-allergenic activity beyond sensitisation, complementing skin tests and IgE measurements.</dc:description><dc:publisher>Blackwell Science, 1997-</dc:publisher><dc:date>2026</dc:date><dc:date>2026-05-12 14:19:10</dc:date><dc:type>Neznano</dc:type><dc:identifier>29369</dc:identifier><dc:identifier>UDK: 616-056.43:615.37</dc:identifier><dc:identifier>ISSN pri članku: 1365-2222</dc:identifier><dc:identifier>DOI: 10.1111/cea.70238Digital Object Identifier (DOI)</dc:identifier><dc:identifier>COBISS_ID: 268422147</dc:identifier><dc:source>Clinical &amp; experimental allergy</dc:source><dc:language>sl</dc:language><dc:rights>© 2026 The Author(s). Clinical &amp; Experimental Allergy published by John Wiley &amp; Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</dc:rights></metadata>
